Abscess treatment involves the use of antimicrobial medications and drainage procedures to treat localized infection or abscesses occurring in various parts of the body such as brain, lungs, liver, skin and others. Abscesses often develop due to bacterial, fungal or parasitic infections and require medical attention to resolve the infection. The global abscess treatment market involves drugs, surgical equipment and other medical devices required to diagnose and treat abscesses. Abscess formation in organs is a serious medical condition necessitating timely intervention. Increasing access to healthcare facilities along with rising pool of surgical procedures for abscess drainage is propelling the abscess treatment market.
The abscess treatment market is estimated to be valued at USD 3.42 Bn in 2024 and is expected to reach USD 5.45 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.88% from 2024 to 2031.
Key players operating in the abscess treatment are Pfizer, GlaxoSmithKline, Abbott Laboratories, Bayer, Eli Lilly and Company.
The rising prevalence of various chronic diseases predisposing to abscess formation such as appendicitis, dental infections and inflammatory bowel disease are presenting lucrative opportunities for players in the Abscess Treatment Market. Moreover, growing healthcare expenditure in developing nations is amplifying the potential patient pool globally. Major companies are actively pursuing global expansion strategies through collaborations with local players and setting up manufacturing units in high growth territories of Asia Pacific and Latin America to leverage potential untapped opportunities.
Market Drivers
Increasing prevalence of dental caries and periodontal gum diseases are major drivers for the abscess treatment market. According to WHO, oral diseases affect nearly 3.5 billion people worldwide with dental caries in permanent teeth being the most prevalent condition. Untreated dental infections often progress to abscess formation necessitating drainage and antibiotic therapy, thereby boosting the market growth.
Market Restrains
High cost of surgical procedures for incision and drainage of deep seated abscesses especially in organs may hinder the market growth. Moreover, growing antibiotic resistance is making abscess treatment challenging. This has led to increased focus on development of novel alternative therapeutics which are still in early stages, restraining revenues in the short term.
Segment Analysis
The abscess treatment market can be segmented based on indication, end-use, and geography. On the basis of indication, the market can be categorized as dental, breast, liver, and others. Among these, the dental segment holds the lion’s share in the market. This segment dominates the market due to the rising prevalence of dental abscess caused by dental infection. According to dental experts, dental abscesses are very common and if left untreated can spread and become life-threatening.
Global Analysis Regionally, North America leads the abscess treatment market and is expected to dominate the market during the forecast period. This is due to high healthcare expenditure and growing awareness about abscess treatment options. Additionally, the strong presence of key players and availability of advanced products in this region propel the market growth. Asia Pacific is projected to be the fastest-growing region in the abscess treatment market during the forecast period. This is attributed to the increasing cases of abscesses caused due to poor oral health, changing lifestyle, and improvement of healthcare infrastructure in emerging countries such as India and China. Rising medical tourism in Asian countries is also supporting the market growth.
Get this Report in Japanese Language: 膿瘍治療市場
Get this Report in Korean Language: 농양 치료 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
